Sellas Life Sciences Group Inc (SLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SLS | ONCY | MIST | ||
| Company | Sellas Life Sciences Group Inc | Oncolytics Biotech Inc | Milestone Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.3300 | 1.0900 | 1.5300 | ||
| High | 1.3400 | 1.1300 | 1.6300 | ||
| Low | 1.2000 | 1.0900 | 1.5300 | ||
| Last | 1.2200 | 1.1000 | 1.5600 | ||
| Change | -0.2400 | +0.0100 | +0.0200 | ||
| % Change | -16.44% | +0.92% | +1.30% | ||
| Volume | 3,230,118 | 112,386 | 74,937 | ||
| 20-Day Average Volume | 1,560,870 | 263,504 | 161,429 | ||
| Previous Close | 1.4600 | 1.0900 | 1.5400 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.4082 | 1.0951 | 1.6965 | ||
| 20-Day Raw Stochastic | 22.88% | 29.21% | 24.32% | ||
| 20-Day Relative Strength | 47.42% | 50.95% | 45.52% | ||
| Weighted Alpha | -4.87 | -47.27 | -39.82 | ||
| Today's Opinion | 64% Buy | 64% Sell | 80% Sell | ||
| Previous Opinion | 88% Buy | 64% Sell | 80% Sell | ||
| Last Month's Opinion | 32% Sell | 88% Sell | 64% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -20.86% since 04/22/24 | +4.98% since 04/22/24 | -2.45% since 04/22/24 | ||
| Low | 1.2000 on 04/29/24 | 1.0294 on 04/24/24 | 1.5000 on 04/25/24 | ||
| High | 1.7200 on 04/23/24 | 1.1300 on 04/29/24 | 1.7200 on 04/23/24 | ||
| 1-Month | |||||
| %Chg | +20.66% since 03/28/24 | +3.00% since 03/28/24 | -11.17% since 03/28/24 | ||
| Low | 0.9750 on 04/01/24 | 1.0100 on 04/16/24 | 1.5000 on 04/25/24 | ||
| High | 1.7200 on 04/23/24 | 1.2900 on 04/04/24 | 1.8700 on 04/04/24 | ||
| 3-Month | |||||
| %Chg | +107.97% since 01/29/24 | -11.24% since 01/29/24 | -8.62% since 01/29/24 | ||
| Low | 0.5510 on 01/30/24 | 0.8830 on 02/07/24 | 1.3600 on 03/14/24 | ||
| High | 1.7200 on 04/23/24 | 1.2900 on 04/04/24 | 2.4000 on 02/26/24 | ||
| 6-Month | |||||
| %Chg | +30.26% since 10/27/23 | -29.10% since 10/27/23 | -30.26% since 10/27/23 | ||
| Low | 0.4986 on 01/26/24 | 0.8830 on 02/07/24 | 1.3300 on 01/22/24 | ||
| High | 1.7200 on 04/23/24 | 1.8000 on 11/03/23 | 3.5200 on 12/05/23 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 82,151 | 82,208 | 81,851 | ||
| Shares Outstanding, K | 56,268 | 75,420 | 53,150 | ||
| Annual Sales | 0 | 0 | 1,000,000 | ||
| Annual Net Income | -37,340,000 | -20,560,000 | -59,690,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -8,140,000 | -2,870,000 | -13,610,000 | ||
| 60-Month Beta | 2.35 | 1.93 | 1.77 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.25 on 03/28/24 | -0.04 on 03/07/24 | -0.32 on 03/21/24 | ||
| Latest Earnings Date | 05/09/24 | 05/03/24 | 05/09/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||